A carregar...
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms
Immune checkpoint inhibition with monoclonal antibodies is becoming increasingly commonplace in cancer medicine, having contributed to a widening of therapeutic options across oncological indications. Disruption of immune tolerance is the key mechanism of action of checkpoint inhibitors and although...
Na minha lista:
| Publicado no: | Immunology |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954715/ https://ncbi.nlm.nih.gov/pubmed/31646612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13141 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|